Beijing Hospital of Integrated Traditional Chinese and Western Medicine
Beijing, Beijing Municipality, 100039, China
NCT Number: NCT02729545
This study evaluates the efficacy and safety in improving ovarian function of polycystic ovarian syndrome in adults. Half of patients will receive Tung's acupuncture therapy, while the other half will receive Diane-35(CPA/EE) as the control group.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Phase 2
Beijing, Beijing Municipality, 100039, China
Both Tung's acupuncture therapy and Diane-35(CPA/EE) could improve the symptom of patients with polycystic ovarian syndrome, but until now there is no definite evidence to indicate acupuncture could play the same role in improving ovarian function. So we design this study to observe the change of follicular development, ovary size and sex hormone( testosterone, follitropin, luteinizing hormone) before and after the treatment, and evaluate the efficacy and safty of acupuncture.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The study took Tung's acupoints as main acupuncture points, which were Fuke, Huanchao, Tianhuang, Renhuang, as well as the traditional acupoints Guanyuan (CV4) and Zigong (EX-CA1).
Cyproterone acetate/ethinylestradiol (CPA/EE) contains 2mg cyproterone acetate (an anti-androgenic progestin) and 0.035mg ethinylestradiol (CPA/EE). The pills were administered for 21 days consecutively. The patients then stopped taking the pills for seven days and, on the eighth day, continued to take the pills again for three menstrual cycles (28 day cycles).
Other names: Diane-35
Time frame: baseline and 12 weeks
the change in LH/FSH ratio, values after 12-week treatment minus the values at baseline
Time frame: baseline to the 24th week
the change in LH/FSH ratio, values at the 24th week minus the values at baseline
Time frame: baseline and 12 weeks
changes in luteinizing hormone(LH), values after 12-week treatment minus the values at baseline
Time frame: baseline and 12 weeks
changes in follicle-stimulating hormone (FSH), values after 12-week treatment minus the values at baseline
Time frame: baseline and 12 weeks
the changes in BMI, values after 12-week treatment minus the values at baseline
Time frame: baseline and 12 weeks
changes in total testosterone (TT) , values after 12-week treatment minus the values at baseline
Time frame: baseline and 12 weeks
changes in ovarian volume, values after 12-week treatment minus the values at baseline
Time frame: baseline and 12 weeks
the changes in polycystic ovary number, values after 12-week treatment minus the values at baseline
Time frame: baseline and 12 weeks
Changes in the number of bleeding events, values after 12-week treatment minus the values at baseline
Beijing Hospital of Integrated Traditional Chinese and Western Medicine
Other
The Efficacy and Safety Study of Tung's Acupuncture for Improving Ovarian Function of Polycystic Ovarian Syndrome: a Randomised Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06813118
Adnexal Diseases, Cysts
Rawalpindi, Punjab Province, Pakistan
View Trial DetailsNCT07387679
Adnexal Diseases, Cysts
Bahawalpur, Punjab Province, Pakistan
View Trial DetailsNCT03717935
Adnexal Diseases, Body Weight
Aurora, Colorado, United States
View Trial DetailsNCT06812559
Adnexal Diseases, Controlled Ovarian Hyperstimulation
Alexandria, Alexandria Governorate, Egypt
View Trial Details